Extent of radiological response does not reflect survival in primary central nervous system lymphoma
暂无分享,去创建一个
W. Stevens | M. J. van den Bent | M. Smits | J. Doorduijn | A. Postma | M. Minnema | D. Brandsma | A. Beeker | T. Seute | J. Bromberg | R. Enting | S. Issa | K. Bakunina | M. van der Meulen | G. Cull | M. V. D. van der Poel
[1] Anne Line Stensjøen,et al. Volumetric segmentation of glioblastoma progression compared to bidimensional products and clinical radiological reports , 2019, Acta Neurochirurgica.
[2] S. Heiland,et al. Automated quantitative tumour response assessment of MRI in neuro-oncology with artificial neural networks: a multicentre, retrospective study. , 2019, The Lancet. Oncology.
[3] F. Barkhof,et al. Inter-rater agreement in glioma segmentations on longitudinal MRI , 2019, NeuroImage: Clinical.
[4] W. Stevens,et al. Rituximab in patients with primary CNS lymphoma (HOVON 105/ALLG NHL 24): a randomised, open-label, phase 3 intergroup study. , 2019, The Lancet. Oncology.
[5] K. Hoang-Xuan,et al. Prognostic value of early 18F-FDG PET scanning evaluation in immunocompetent primary CNS lymphoma patients , 2018, Oncotarget.
[6] Jong Hoon Kim,et al. Interim 18F-FGD PET/CT may not predict the outcome in primary central nervous system lymphoma patients treated with sequential treatment with methotrexate and cytarabine , 2017, Annals of Hematology.
[7] R. Vernhout,et al. Comparison of 2D (RANO) and volumetric methods for assessment of recurrent glioblastoma treated with bevacizumab—a report from the BELOB trial , 2017, Neuro-oncology.
[8] R. Houot,et al. Patterns of response and relapse in primary CNS lymphomas after first-line chemotherapy: imaging analysis of the ANOCEF-GOELAMS prospective randomized trial , 2016, Neuro-oncology.
[9] R. Fisher,et al. Role of imaging in the staging and response assessment of lymphoma: consensus of the International Conference on Malignant Lymphomas Imaging Working Group. , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[10] Bruce D Cheson,et al. Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification. , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[11] John H. Sampson,et al. A novel, reproducible, and objective method for volumetric magnetic resonance imaging assessment of enhancing glioblastoma. , 2014, Journal of neurosurgery.
[12] Jong-Hee Chang,et al. Early response to high-dose methotrexate, vincristine, and procarbazine chemotherapy-adapted strategy for primary CNS lymphoma: no consolidation therapy for patients achieving early complete response , 2014, Annals of Hematology.
[13] E. Thiel,et al. High-dose methotrexate with or without whole brain radiotherapy for primary CNS lymphoma (G-PCNSL-SG-1): a phase 3, randomised, non-inferiority trial. , 2010, The Lancet. Oncology.
[14] Alfons G H Kessels,et al. Intraobserver and Interobserver Agreement in Volumetric Assessment of Glioblastoma Multiforme Resection , 2010, Neurosurgery.
[15] R. Fimmers,et al. Early complete response during chemotherapy predicts favorable outcome in patients with primary CNS lymphoma. , 2010, Neuro-oncology.
[16] D. Nelson,et al. Primary central nervous system lymphoma: the Memorial Sloan-Kettering Cancer Center prognostic model. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[17] E. Thiel,et al. Primary central nervous system lymphomas (PCNSL): MRI response criteria revised , 2005, Neurology.
[18] J. Armitage,et al. Report of an international workshop to standardize baseline evaluation and response criteria for primary CNS lymphoma. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[19] F Barkhof,et al. Interobserver variability in the radiological assessment of response to chemotherapy in glioma , 2003, Neurology.
[20] J. Blay,et al. Prognostic scoring system for primary CNS lymphomas: the International Extranodal Lymphoma Study Group experience. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[21] J R Anderson,et al. Analysis of survival by tumor response. , 1983, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[22] Jacob Cohen. A Coefficient of Agreement for Nominal Scales , 1960 .